Treatment Guidelines from The Medical Letter
FROM
ISSUE
69
May 1, 2008
View Complete Issue         Table of Contents 2019 
Antiplatelet and Anticoagulant Drugs
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Antiplatelet and Anticoagulant Drugs
May 1, 2008 (Issue: 69)
Arterial and venous thrombosis are major causes of morbidity and mortality. Arterial thrombi consist of platelet aggregates held together by small amounts of fibrin. Antiplatelet drugs are the drugs of choice for prevention and treatment of arterial...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Antiplatelet and Anticoagulant Drugs
Article code: 69a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.